Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1339159
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1339159
Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Share, Size, Trends, Industry Analysis Report, By Application (Infectious Disease, Immunological Disease, Cancer, Others) By Region; Segment Forecast, 2023 - 2032
PUBLISHED:
PAGES: 118 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market size is expected to reach USD 1,08,553.86 thousands by 2032, according to a new study by Polaris Market Research. The report "Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Share, Size, Trends, Industry Analysis Report, By Application (Infectious Disease, Immunological Disease, Cancer, Others) By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Global NHP pre-clinical studies are an essential step in the development of new drugs and vaccines, and CROs provide a cost-effective solution for conducting such studies. Recent advances in genomics and other technologies have improved our understanding of NHP biology and facilitated the use of NHPs in pre-clinical studies. However, the use of NHPs in research remains controversial, and there is a growing trend toward the development of alternative methods for pre-clinical testing that do not involve the use of animals.
Recent advances in genomics and other technologies have enabled a better understanding of NHP biology and improved the development of NHP models for translational research. These advances have also facilitated the use of NHPs in pre-clinical studies, allowing for a more comprehensive assessment of the safety and efficacy of new drugs and vaccines.
NHPs in pre-clinical studies at CROs in North America has become an essential step in drug development. The integration of new technologies and the upgradation of NHP models for translational research have improved the accuracy and efficacy of NHP pre-clinical studies.
While the use of NHPs in pre-clinical studies remains controversial due to ethical concerns, CROs adhere to strict ethical guidelines and regulations to ensure the welfare of animals used in research. Additionally, CROs work closely with regulatory agencies to ensure that the pre-clinical studies meet safety and efficacy requirements before advancing to clinical trials.
CROs in Europe follow strict ethical guidelines and regulations to ensure animal welfare and regulatory agencies oversee the safety and efficacy of pre-clinical studies. While the use of NHPs in pre-clinical studies remains controversial, these studies remain an essential step in drug development.
There is a growing trend towards the upgradation of NHP models for translational research, with more focus on using NHPs that have specific disease phenotypes. For example, NHP models of Alzheimer's disease, Parkinson's disease, and HIV infection have been developed to better understand the pathogenesis of these diseases and test new treatments.
However, the use of NHPs in pre-clinical studies remains controversial, and animal rights activists continue to voice their concerns about animal welfare. Many organizations have called for the development of alternative methods for pre-clinical testing that do not involve the use of animals.
Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Report Highlights
The increasing interest in using non-human primate (NHP) based preclinical trials for research purposes has led to a significant boost in the growth of this segment.
North America witnesses the significant growth for the Non-Human Primate Pre-clinical studies at Contract Research Organizations periodically for the development and to identify cohorts of animals with specific phenotypes across centers.
The global players include: ABL, Inc., Applied BioCode Corporation, BioLegend, Inc., Exocell, Inc., HUREL Corporation, iQ Biosciences, and Mabtech AB, among others.
Polaris Market Research has segmented the Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market report based on Application and Region:
Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market,
Application Outlook (Revenue, USD Thousands, 2019-2032)
- Infectious Disease
- Immunological Disease
- Cancer
- Cardiovascular Disease
- Metabolic Diseases
- Genetic Disease
- Respiratory Diseases
- Neurological Disease
- Female Related Diseases
- Others
Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, Regional Outlook (Revenue - USD Thousands, 2019-2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Product Code: PM3539
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Insights
- 4.1. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Industry Snapshot
- 4.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Innovations in CRISPR technologies leading to increased adoption in NHP preclinical trials
- 4.2.1.2. Rising Geriatric Population and Rising Prevalence of Target Diseases
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Procedure Costs and Presence of Ambiguous Regulatory Framework
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Value Chain Analysis
- 4.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Industry trends
- 4.7. COVID-19 Impact Analysis
5. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 5.3. Infectious Disease
- 5.3.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Infectious Disease, by Region, 2019-2032 (USD Million)
- 5.4. Immunological Disease
- 5.4.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Immunological Disease, by Region, 2019-2032 (USD Million)
- 5.5. Cancer
- 5.5.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Cancer, by Region, 2019-2032 (USD Million)
- 5.6. Cardiovascular Disease
- 5.6.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Cardiovascular Disease, by Region, 2019-2032 (USD Million)
- 5.7. Metabolic Diseases
- 5.7.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Metabolic Diseases, by Region, 2019-2032 (USD Million)
- 5.8. Genetic Disease
- 5.8.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Genetic Disease, by Region, 2019-2032 (USD Million)
- 5.9. Respiratory Diseases
- 5.9.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Respiratory Diseases, by Region, 2019-2032 (USD Million)
- 5.10. Neurological Disease
- 5.10.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Neurological Disease, by Region, 2019-2032 (USD Million)
- 5.11. Female Related Diseases
- 5.11.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Female Related Diseases, by Region, 2019-2032 (USD Million)
- 5.12. Others
- 5.12.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Geography
- 6.1. Key findings
- 6.2. Introduction
- 6.2.1. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Assessment, By Geography, 2019-2032 (USD Million)
- 6.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - North America
- 6.3.1. North America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.3.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - U.S.
- 6.3.2.1. U.S.: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.3.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Canada
- 6.3.3.1. Canada: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Europe
- 6.4.1. Europe: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.4.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - UK
- 6.4.2.1. UK: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.4.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - France
- 6.4.3.1. France: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.4.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Germany
- 6.4.4.1. Germany: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.4.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Italy
- 6.4.5.1. Italy: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.4.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Spain
- 6.4.6.1. Spain: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.4.7. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Netherlands
- 6.4.7.1. Netherlands: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.4.8. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Austria
- 6.4.8.1. Austria: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Asia Pacific
- 6.5.1. Asia Pacific: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.5.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - China
- 6.5.2.1. China: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.5.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - India
- 6.5.3.1. India: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.5.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Malaysia
- 6.5.4.1. Malaysia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.5.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Japan
- 6.5.5.1. Japan: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.5.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Indonesia
- 6.5.6.1. Indonesia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.5.7. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - South Korea
- 6.5.7.1. South Korea: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Middle East & Africa
- 6.6.1. Middle East & Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.6.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Saudi Arabia
- 6.6.2.1. Saudi Arabia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.6.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - UAE
- 6.6.3.1. UAE: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.6.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Israel
- 6.6.4.1. Israel: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.6.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - South Africa
- 6.6.5.1. South Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.7. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Latin America
- 6.7.1. Latin America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.7.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Mexico
- 6.7.2.1. Mexico: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.7.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Brazil
- 6.7.3.1. Brazil: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- 6.7.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Argentina
- 6.7.4.1. Argentina: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
7. Competitive Landscape
- 7.1. Expansion and Acquisition Analysis
- 7.1.1. Expansion
- 7.1.2. Acquisitions
- 7.2. Partnerships/Collaborations/Agreements/Exhibitions
8. Company Profiles
- 8.1. ABL, Inc
- 8.1.1. Company Overview
- 8.1.2. Financial Performance
- 8.1.3. Product Benchmarking
- 8.1.4. Recent Development
- 8.2. Applied BioCode Corporation
- 8.2.1. Company Overview
- 8.2.2. Financial Performance
- 8.2.3. Product Benchmarking
- 8.2.4. Recent Development
- 8.3. BioLegend, Inc
- 8.3.1. Company Overview
- 8.3.2. Financial Performance
- 8.3.3. Product Benchmarking
- 8.3.4. Recent Development
- 8.4. Exocell, Inc
- 8.4.1. Company Overview
- 8.4.2. Financial Performance
- 8.4.3. Product Benchmarking
- 8.4.4. Recent Development
- 8.5. HUREL Corporation
- 8.5.1. Company Overview
- 8.5.2. Financial Performance
- 8.5.3. Product Benchmarking
- 8.5.4. Recent Development
- 8.6. iQ Biosciences
- 8.6.1. Company Overview
- 8.6.2. Financial Performance
- 8.6.3. Product Benchmarking
- 8.6.4. Recent Development
- 8.7. Mabtech AB
- 8.7.1. Company Overview
- 8.7.2. Financial Performance
- 8.7.3. Product Benchmarking
- 8.7.4. Recent Development
Product Code: PM3539
List of Tables
- Table 1 Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 2 Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Assessment, By Geography, 2019-2032 (USD Million)
- Table 3 North America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 4 U.S.: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 5 Canada: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 6 Canada: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 7 Europe: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 8 Spain: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 9 Netherlands: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 10 Austria: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 11 Germany: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 12 Italy: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 13 France: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 14 Asia Pacific: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 15 China: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 16 Japan: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 17 India: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 18 Indonesia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 19 South Korea: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 20 Malaysia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 21 Latin America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 22 Brazil: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 23 Mexico: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 24 Argentina: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 25 Middle East & Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 26 South Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 27 Israel: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 28 Saudi Arabia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
- Table 29 UAE: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
List of Figures
- Figure 1 Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, 2019-2032 (USD Million)
- Figure 2 Integrated Ecosystem
- Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4 Market by Geography
- Figure 5 Porter's Five Forces
- Figure 6 Market by Application
- Figure 7 Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2022 & 2032 (USD Million)
- Figure 8 Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Assessment, By Geography, 2019-2032 (USD Million)
- Figure 9 Strategic Analysis - Non-Human Primate Pre-clinical studies at Contract Research Organizations Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.